<SEC-DOCUMENT>0001193125-20-085077-index.html : 20200325
<SEC-HEADER>0001193125-20-085077.hdr.sgml : 20200325
<ACCEPTANCE-DATETIME>20200325161658
ACCESSION NUMBER:		0001193125-20-085077
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20200325
DATE AS OF CHANGE:		20200325
EFFECTIVENESS DATE:		20200325

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Novus Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001404281
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-237380
		FILM NUMBER:		20742356

	BUSINESS ADDRESS:	
		STREET 1:		19900 MACARTHUR BLVD.
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612
		BUSINESS PHONE:		949-238-8090

	MAIL ADDRESS:	
		STREET 1:		19900 MACARTHUR BLVD.
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tokai Pharmaceuticals Inc
		DATE OF NAME CHANGE:	20070622
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d865611ds8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: d865611ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d865611dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d865611dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d865611dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d865611dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>d865611dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
Document 4 - file: d865611dex232.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g865611page6a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g865611page6a.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g865611page6b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g865611page6b.jpg

</DOCUMENT>
</SEC-DOCUMENT>